Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To compare the overall survival of subjects with advanced HCC who have progressed on/after or are intolerant to sorafenib and receive brivanib plus best supportive care (BSC) to those receiving placebo plus BSC.
Critère d'inclusion
- Advanced Hepatocellular Carcinoma